Purpose

70 million individuals worldwide experience epileptic seizures, with 80% residing in low-income regions that may cause access to specialized healthcare to be difficult. Microelectrode Arrays (MEAs) have emerged as a new and promising technology that can be used to evaluate electrophysiologically active cells in vitro. With the potential of MEA technology, the purpose of our device is to reach low-income areas and aid in diagnosis before the patient experiences symptoms of epilepsy.

Learn More

Our Product

Our team developed a low-cost microelectrode array system capable of recording neuronal voltage signals to aid specialists in diagnosing patients with epilepsy in low-income regions. This device ensures affordability and portability by optimizing the most cost efficient materials without compromising the effectiveness of our device.

Learn More

MEA System Market

  • Market Strategy

    Discover our targeted market strategy, exploring our defined user base, the expanding market potential, and competitive pricing.

  • Competitors

    Uncover the unique advantages the AJAYA MEA System holds in our competitor analysis chart, detailing why we stand above the rest.

Learn More

Meet the Team

  • Yash Khadilkar

    Team Lead

  • Albert Garcia

    Co-Hardware Lead

  • Abeline Hernandez

    Co-Hardware Lead

  • Jeremiah Andrade

    Circuitry Lead

  • Ashley Varatip

    Testing and Verification Lead

Learn More